Ageing is the main risk factor for major non-communicable chronic lung diseases, including chronic obstructive pulmonary disease, most forms of lung cancer and idiopathic pulmonary fibrosis. While the prevalence of these diseases continually increases with age, their respective incidence peaks at different times during the lifespan, suggesting specific effects of ageing on the onset and/or path...

Background: Vitamin D (Vit D) is linked to various conditions including musculoskeletal, metabolic and   cardiopulmonary diseases. However, it is not clear whether correction of vit D deficiency exerts any beneficial effect in patients with pulmonary hypertension. Methods: This study was a prospective uncontrolled longitudinal study. Patients with pulmonary hypertension and vit D d...

T he interstitial lung diseases, like many chronic lung diseases, may lead to the development of pulmonary hypertension and cor pulmonale. The prevalence of pulmonary hypertension in these diseases is unknown, however. Current data suggest that prevalence varies with the type ofinterstitial disease.'3 In a group of patients with either idiopathic pulmonary fibrosis or interstitial lung disease ...

Vessel Plus is an open acccess journal, which publishes articles related to vascular diseases, including acute respiratory distress syndrome, aneurysm, atherosclerosis, hypertension, stroke, peripheral or pulmonary etc.

Phosphodiesterase inhibitors (PDE) can be used as therapeutic agents for various diseases such as dementia, depression, schizophrenia and erectile dysfunction in men, as well as congestive heart failure, chronic obstructive pulmonary disease, rheumatoid arthritis, other inflammatory diseases, diabetes and various other conditions. In this review we will concentrate on one type of PDE, mainly PD...

Pulmonary surfactant protein A (SP-A) is used as a biomarker to understand the clinical features of pulmonary diseases and associated prognostic indices in human medicine. This study was conducted to investigate whether or not serum SP-A concentration can be used as a biomarker for identifying pulmonary parenchymal diseases in dogs. Thirty-two dogs with pulmonary parenchymal diseases, 34 with n...

Over the last decade, deep learning (DL) has contributed to a paradigm shift in computer vision and image recognition creating widespread opportunities of using artificial intelligence research as well industrial applications. DL been extensively studied medical imaging applications, including those related pulmonary diseases. Chronic obstructive disease, asthma, lung cancer, pneumonia, and, mo...

Pulmonary overflow (PO) is a common finding in left-to-right shunting congenital heart diseases (CHD). B-line artifacts are seen on lung ultrasound the presence of extravascular water.

In 2008, the Nontuberculous Mycobacteriosis Control Committee of the Japanese Society for Tuberculosis and the Scientifi c Assembly for Infection and Tuberculosis of the Japanese Respiratory Society (hereinafter, the Joint Guidelines Committee) published the Guidelines for chemotherapy of pulmonary nontuberculous mycobacterial disease─2008 interim guidelines 1). In the background, rifabutin (RB...